Arthroscopy The Journal of Arthroscopic and Related Surgery· 2026Q1· Review
Bone Marrow Aspirate Augmentation Reduces Reoperation Rates After Osteochondral Allograft Transplantation of the Knee: A Systematic Review
- 0citations
- Q1SCImago
- 2026year
Short summary
Augmenting knee osteochondral allografts (OCAs) with bone marrow aspirate (BMA) significantly reduces reoperation rates (2.4% vs 21.9%) compared to non-augmented grafts, according to a systematic review of four studies (165 knees).
AI-generated from the title and abstract; the full text is not read.
Key points
- Bone marrow aspirate (BMA) augmentation of knee osteochondral allografts (OCAs) is associated with substantially lower reoperation rates (2.4% vs 21.9%).
- Early radiographic evidence suggests improved subchondral remodeling with BMA augmentation at 6 months.
- Magnetic resonance imaging-based scores and patient-reported outcomes (IKDC, KOOS) did not show consistent significant differences between augmented and non-augmented grafts.
- A trend favored BMA for achieving minimal clinically important differences in patient-reported outcomes (88% vs 55%).
AI-generated from the title and abstract; the full text is not read.
Abstract
PURPOSE: To systematically review the clinical, radiographic, and patient-reported outcomes of osteochondral allograft (OCA) transplantation with versus without bone marrow aspirate (BMA) augmentation for the treatment of knee cartilage defects. METHODS: A comprehensive search was performed according to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Comparative clinical studies assessing OCA with and without BMA were included. Two reviewers independently performed screening, data extraction, and methodological quality assessment using the Cochrane Risk of Bias Tool 2.0 for randomized trials and the Methodological Index for Non-Randomized Studies for nonrandomized studies. RESULTS: Four studies (3 Level III, 1 Level I) involving 165 knees met the inclusion criteria. The mean follow-up duration across studies ranged from 5.5 to 18.0 months. Across 2 comparative studies, BMA augmentation was associated with fewer reoperations (2.4% vs 21.9%) compared with non-BMA augmentation. Radiographic findings were heterogeneous: 1 study showed earlier integration and reduced sclerosis with BMA at 6 months, whereas 2 magnetic resonance imaging-based studies showed no differences in OCA Magnetic Resonance Imaging Scoring System scores. Computed tomography assessment in 1 trial found increased small cysts but a trend toward fewer large cysts in BMA-treated grafts. Patient-reported outcomes from 1 study showed no significant differences in International Knee Documentation Committee or Knee injury and Osteoarthritis Outcome Score for Joint Replacement scores between groups, although achievement of the Knee injury and Osteoarthritis Outcome Score for Joint Replacement minimal clinically important difference favored the BMA cohort (88% vs 55%; P = .076). CONCLUSIONS: OCA transplantation augmented with BMA is associated with significantly lower reoperation rates compared with nonaugmented transplantation. Although short-term radiographic data show improved early subchondral remodeling, these findings are not consistently corroborated by magnetic resonance imaging-based scores. LEVEL OF EVIDENCE: Level III, systematic review of Level I and III studies.
The authors' abstract, as published at the source. Arthroscopy The Journal of Arthroscopic and Related Surgery, 2026 · DOI ↗
The rest is in the Pofolia app
Takeaways and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Rheumatology
RheumatologyMedicine